Clinical Trials Logo

Tobacco-Related Carcinoma clinical trials

View clinical trials related to Tobacco-Related Carcinoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06448351 Recruiting - Clinical trials for Tobacco-Related Carcinoma

Manipulating E-Cigarette Nicotine to Promote Public Health

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

This clinical trial explores the manipulation of e-cigarette (EC) nicotine to promote public health. Researchers are trying to understand and gather information about how the strength, form, and structure of nicotine in products play a significant role in their potential for addiction and how they might affect health risks. The information gained from this study may allow researchers to understand how these aspects of nicotine influence the potential for addiction, how people puff on ECs, how the body processes nicotine, and any potential harmful effects it might have on health. Exploring these specific characteristics of nicotine may also determine if an EC product standard could help identify optimal nicotine levels for users.

NCT ID: NCT05876091 Recruiting - Clinical trials for Tobacco-Related Carcinoma

Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

This clinical trial tests the effect of tobacco flavor and liquid composition on the way a person puffs on a vape (topography). In general, tobacco products are designed with sensory factors in mind, such as flavor, to increase the appeal. Flavors and the composition of nicotine, either made in a lab (synthetic) or from tobacco, may create positive sensory effects, such as look, feel and taste, and influence smoking behavior and willingness to try different types of cigarettes. Understanding how nicotine vaping products are used is important in assessing individual and population level health risks. Vape flavors and synthetic nicotine may be related to harmful effects on health from vaping and may impact the appeal, risk beliefs and vaping topography.

NCT ID: NCT05730439 Recruiting - Clinical trials for Tobacco-Related Carcinoma

Examining the Impact of Nicotine Pouches in Rural Ohio and Ohio Appalachia

Start date: May 12, 2023
Phase: Early Phase 1
Study type: Interventional

This clinical trial examines the impact of nicotine patches on preventing cancer in rural and Appalachia Ohio residents. Nicotine pouches are new smokeless tobacco products that are marketed as substitutes for smokeless tobacco and are gaining in popularity. There is little research on how nicotine pouches will be adopted by residents of Ohio Appalachia and rural Ohio. This study may help researchers better understand the appeal and potential impact of nicotine pouches on public health.

NCT ID: NCT05679349 Recruiting - Lung Carcinoma Clinical Trials

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.

NCT ID: NCT04949464 Recruiting - HIV Infection Clinical Trials

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

Start date: March 22, 2023
Phase: N/A
Study type: Interventional

This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.

NCT ID: NCT04340531 Recruiting - Clinical trials for Tobacco-Related Carcinoma

Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities

Start date: January 30, 2021
Phase: Phase 4
Study type: Interventional

This phase IV trial examines the effectiveness of a multi-level smoking cessation program for high-risk women in rural communities. Cigarette smoking is a major risk factor for cervical cancer in women. Rural primary care practices and providers often lack the electronic health record support to pre-identify smokers for services, as well as lack the necessary counseling training and access to comprehensive cessation programs. Implementing evidence-based smoking cessation programs in rural Appalachia may decrease the rates of cigarette smoking and as a result decrease the rates of cervical cancer.